News Image

NYSE:DOCS qualifies as a high growth stock and is consolidating.

By Mill Chart

Last update: May 7, 2024

Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if DOXIMITY INC-CLASS A (NYSE:DOCS) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted DOXIMITY INC-CLASS A showing up in our growth with base formation screen, so it may be worth spending some more time on it.

Growth Examination for NYSE:DOCS

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:DOCS boasts a 8 out of 10:

  • DOCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.62%, which is quite impressive.
  • Measured over the past years, DOCS shows a very strong growth in Earnings Per Share. The EPS has been growing by 106.72% on average per year.
  • Looking at the last year, DOCS shows a quite strong growth in Revenue. The Revenue has grown by 16.57% in the last year.
  • The Revenue has been growing by 53.27% on average over the past years. This is a very strong growth!
  • DOCS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.36% yearly.
  • DOCS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.59% yearly.

How do we evaluate the Health for NYSE:DOCS?

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:DOCS scores a 9 out of 10:

  • An Altman-Z score of 22.21 indicates that DOCS is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 22.21, DOCS belongs to the top of the industry, outperforming 94.87% of the companies in the same industry.
  • DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • DOCS has a Current Ratio of 8.03. This indicates that DOCS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 8.03, DOCS belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • DOCS has a Quick Ratio of 8.03. This indicates that DOCS is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of DOCS (8.03) is better than 92.31% of its industry peers.

How do we evaluate the Profitability for NYSE:DOCS?

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:DOCS was assigned a score of 9 for profitability:

  • With an excellent Return On Assets value of 13.76%, DOCS belongs to the best of the industry, outperforming 97.44% of the companies in the same industry.
  • DOCS has a better Return On Equity (15.92%) than 97.44% of its industry peers.
  • DOCS has a Return On Invested Capital of 15.40%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 4.93%.
  • Looking at the Profit Margin, with a value of 29.39%, DOCS belongs to the top of the industry, outperforming 97.44% of the companies in the same industry.
  • DOCS's Profit Margin has improved in the last couple of years.
  • DOCS has a Operating Margin of 34.75%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
  • DOCS's Operating Margin has improved in the last couple of years.
  • The Gross Margin of DOCS (88.94%) is better than 97.44% of its industry peers.

How does the Setup look for NYSE:DOCS

Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NYSE:DOCS this score is currently 7:

DOCS has a bad technical rating, but it does show a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 24.61. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 24.15, a Stop Loss order could be placed below this zone. We notice that large players showed an interest for DOCS in the last couple of days, which is a good sign.

Our Strong Growth screener lists more Strong Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of DOCS

For an up to date full technical analysis you can check the technical report of DOCS

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

DOXIMITY INC-CLASS A

NYSE:DOCS (5/17/2024, 7:04:00 PM)

After market: 28.1499 +0.12 (+0.43%)

28.03

+4.29 (+18.07%)

DOCS News

News Image2 hours ago - TheNewswire.comROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

WHY: NEW YORK, NY - (NewMediaWire) - May 19, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 17, 2024 lead plaintiff deadline.

News Image2 hours ago - NewMediaWireROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

News Image2 days ago - ClaimsFilerDOXIMITY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS

/PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications...

News Image2 days ago - Faruqi & Faruqi, LLPDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the...

News Image2 days ago - The Motley FoolWhy Doximity Stock Is Skyrocketing Today

Investors found a lot to like about the healthcare technology company's latest quarterly update.

News Image2 days ago - Market News VideoDoximity Breaks Above 200-Day Moving Average - Bullish for DOCS
News Image3 days ago - Bragar Eagel & SquireBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm
News Image3 days ago - InvestorPlaceDOCS Stock Earnings: Doximity Beats EPS, Beats Revenue for Q4 2024

DOCS stock results show that Doximity beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.

News Image3 days ago - BusinessInsiderDOCS Stock Earnings: Doximity Beats EPS, Beats Revenue for Q4 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Doximity (NYSE:DOCS) just reported results for the fourth quarter of 2024.Doxim...

News Image3 days ago - TheNewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

WHY: NEW YORK, NY - (NewMediaWire) - May 16, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 17, 2024 lead plaintiff deadline.

News Image3 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.

What's going on in today's after hours session

News Image11 days ago - ChartmillNYSE:DOCS is showing decent growth, but is still valued reasonably.

Looking for growth without the hefty price tag? Consider DOXIMITY INC-CLASS A (NYSE:DOCS).

DOCS Links
Follow us for more